Baroda BNP Paribas Health and Wellness Fund
Holdings
32
Concentrated
Top 10 weight
59%
Concentration
Strategy data
N/A
Not reported
Equity
96%
Asset allocation
Portfolio
5Sectors
7Large positions
72.1%Top: Pharmaceuticals & Biotechnology
0.0%Cash
Market-cap allocation
Large cap32%
Mid cap39%
Small cap25%
Asset allocation
Equity96%
Debt1%
Top holdings
8.8%
8.6%
6.7%
Lupin LimitedEQUITY
6.5%5.7%
5.4%
Laurus Labs LimitedEQUITY
5.2%4.6%
4.1%
3.4%
3.1%
Mankind Pharma LimitedEQUITY
3.1%Aurobindo Pharma LimitedEQUITY
3.0%2.5%
2.5%
2.5%
Abbott India LimitedEQUITY
2.4%Net Receivables / (Payables)DERIVATIVE
2.4%2.3%
2.2%
Concord Biotech LimitedEQUITY
2.1%1.7%
1.5%
1.4%
Ajanta Pharma LimitedEQUITY
1.4%Gland Pharma LimitedEQUITY
1.2%Cipla LimitedEQUITY
1.1%1.1%
1.1%
Clearing Corporation of India LtdCASH_EQUIVALENT
0.98%0.96%
0.64%
AI Smart summary
Portfolio read
- 96% equity.
- 32 disclosed positions across 5 classified equity sectors.
- Largest equity sector is Pharmaceuticals & Biotechnology at 72.1% of the portfolio.
Watchpoints
- Sector concentration is elevated: Pharmaceuticals & Biotechnology represents 72%.
Auto-generated from fund metrics. Educational only - not investment advice.
Peer comparison
Other funds in Sectoral / Thematic.
HDFC Manufacturing fund91 holdings · 34% top 10 · 80% AS
UTI Quant Fund89 holdings · 36% top 10
Icici Prudential Energy Opportunities Fund88 holdings · 43% top 10 · 83% AS
ICICI Prudential Business Cycle Fund86 holdings · 50% top 10 · 70% AS
Edelweiss Technology Fund84 holdings · 54% top 10
Axis Business Cycles Fund81 holdings · 29% top 10 · 67% AS
Sector exposure
Full industry / sector breakdown aggregated from the fund's holdings.
72.1%
18.8%
2.3%
1.4%
1.1%